Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
DNA Helicases | 12 | 2024 | 51 | 5.930 |
Why?
|
Transcription Factors | 14 | 2024 | 511 | 4.680 |
Why?
|
Endothelial Cells | 15 | 2024 | 324 | 4.600 |
Why?
|
Neovascularization, Physiologic | 13 | 2021 | 123 | 3.790 |
Why?
|
Nuclear Proteins | 9 | 2024 | 245 | 3.720 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2021 | 18 | 2.850 |
Why?
|
Blood Vessels | 9 | 2022 | 58 | 2.680 |
Why?
|
Gene Expression Regulation, Developmental | 11 | 2024 | 117 | 2.470 |
Why?
|
Embryo, Mammalian | 7 | 2020 | 28 | 2.130 |
Why?
|
Chromatin Assembly and Disassembly | 4 | 2024 | 17 | 1.640 |
Why?
|
Mice | 30 | 2024 | 4399 | 1.640 |
Why?
|
Liver | 4 | 2018 | 415 | 1.470 |
Why?
|
Lymphatic Vessels | 3 | 2022 | 17 | 1.440 |
Why?
|
Animals | 34 | 2024 | 9943 | 1.350 |
Why?
|
Capillaries | 3 | 2019 | 32 | 1.310 |
Why?
|
Fibrinolysin | 3 | 2018 | 15 | 1.280 |
Why?
|
Chromatin | 4 | 2019 | 73 | 1.260 |
Why?
|
Signal Transduction | 9 | 2024 | 1338 | 1.140 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 3 | 2022 | 8 | 0.990 |
Why?
|
Transcriptional Regulator ERG | 2 | 2023 | 10 | 0.950 |
Why?
|
Interleukin-1beta | 2 | 2022 | 42 | 0.950 |
Why?
|
Mice, Inbred C57BL | 11 | 2024 | 1471 | 0.870 |
Why?
|
Atherosclerosis | 2 | 2024 | 91 | 0.870 |
Why?
|
Cells, Cultured | 11 | 2024 | 968 | 0.860 |
Why?
|
Communicable Diseases | 1 | 2023 | 19 | 0.850 |
Why?
|
DNA-Binding Proteins | 4 | 2024 | 482 | 0.850 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2021 | 55 | 0.840 |
Why?
|
Mice, Knockout | 10 | 2024 | 781 | 0.820 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 627 | 0.810 |
Why?
|
Omentum | 1 | 2022 | 4 | 0.800 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2021 | 7 | 0.770 |
Why?
|
Lung | 1 | 2024 | 349 | 0.770 |
Why?
|
Wnt Proteins | 2 | 2012 | 32 | 0.760 |
Why?
|
Epigenesis, Genetic | 3 | 2018 | 144 | 0.750 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 7 | 0.730 |
Why?
|
Oncogene Proteins | 1 | 2020 | 21 | 0.730 |
Why?
|
Eye | 1 | 2020 | 35 | 0.730 |
Why?
|
NF-kappa B | 1 | 2021 | 187 | 0.710 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 93 | 0.700 |
Why?
|
Transcription, Genetic | 4 | 2017 | 399 | 0.680 |
Why?
|
Embryonic Stem Cells | 1 | 2019 | 8 | 0.670 |
Why?
|
Hematopoietic Stem Cells | 2 | 2017 | 58 | 0.640 |
Why?
|
Extracellular Matrix | 2 | 2024 | 111 | 0.640 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 276 | 0.640 |
Why?
|
Acetaminophen | 1 | 2018 | 11 | 0.630 |
Why?
|
Drug Overdose | 1 | 2018 | 10 | 0.630 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2018 | 8 | 0.630 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2018 | 23 | 0.620 |
Why?
|
Mice, Transgenic | 6 | 2021 | 487 | 0.620 |
Why?
|
GATA4 Transcription Factor | 1 | 2017 | 1 | 0.570 |
Why?
|
Disease Models, Animal | 6 | 2024 | 1392 | 0.560 |
Why?
|
Yolk Sac | 4 | 2012 | 5 | 0.560 |
Why?
|
Trans-Activators | 1 | 2017 | 113 | 0.550 |
Why?
|
Human Umbilical Vein Endothelial Cells | 4 | 2023 | 50 | 0.550 |
Why?
|
Cell Line | 5 | 2021 | 672 | 0.510 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 439 | 0.510 |
Why?
|
Macrophages | 3 | 2024 | 273 | 0.500 |
Why?
|
Embryonic Development | 3 | 2014 | 21 | 0.480 |
Why?
|
Proteolysis | 1 | 2013 | 55 | 0.450 |
Why?
|
COUP Transcription Factor II | 1 | 2013 | 1 | 0.430 |
Why?
|
Vesicular Transport Proteins | 4 | 2006 | 30 | 0.430 |
Why?
|
Body Patterning | 1 | 2013 | 7 | 0.430 |
Why?
|
Macular Degeneration | 2 | 2024 | 79 | 0.430 |
Why?
|
Veins | 1 | 2013 | 19 | 0.430 |
Why?
|
Neovascularization, Pathologic | 4 | 2021 | 144 | 0.430 |
Why?
|
Phenotype | 4 | 2024 | 664 | 0.390 |
Why?
|
Endothelium, Vascular | 4 | 2021 | 305 | 0.380 |
Why?
|
Gene Deletion | 4 | 2020 | 115 | 0.370 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 243 | 0.360 |
Why?
|
Angiogenesis Inhibitors | 2 | 2021 | 104 | 0.350 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2021 | 28 | 0.340 |
Why?
|
Humans | 17 | 2024 | 26789 | 0.340 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2021 | 129 | 0.340 |
Why?
|
Carrier Proteins | 3 | 2006 | 244 | 0.330 |
Why?
|
Animals, Newborn | 3 | 2020 | 163 | 0.310 |
Why?
|
Erythropoiesis | 1 | 2007 | 9 | 0.300 |
Why?
|
Retinal Vessels | 2 | 2020 | 71 | 0.290 |
Why?
|
Erythrocytes | 2 | 2022 | 83 | 0.290 |
Why?
|
Embryo Loss | 2 | 2020 | 2 | 0.260 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 2 | 2016 | 11 | 0.250 |
Why?
|
Male | 11 | 2024 | 12854 | 0.240 |
Why?
|
Fibrosis | 2 | 2024 | 115 | 0.240 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2024 | 1 | 0.240 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2024 | 10 | 0.240 |
Why?
|
Talin | 1 | 2024 | 2 | 0.240 |
Why?
|
Mice, Knockout, ApoE | 1 | 2024 | 5 | 0.240 |
Why?
|
Receptors, LDL | 1 | 2024 | 28 | 0.240 |
Why?
|
Organogenesis | 1 | 2024 | 12 | 0.240 |
Why?
|
Extracellular Matrix Proteins | 1 | 2024 | 27 | 0.230 |
Why?
|
Myeloid Cells | 1 | 2024 | 27 | 0.230 |
Why?
|
Adaptor Proteins, Vesicular Transport | 2 | 2014 | 31 | 0.230 |
Why?
|
Cell Adhesion | 1 | 2024 | 132 | 0.230 |
Why?
|
Female | 10 | 2020 | 14434 | 0.230 |
Why?
|
Apoptosis | 3 | 2020 | 739 | 0.230 |
Why?
|
Retinal Pigment Epithelium | 1 | 2024 | 90 | 0.220 |
Why?
|
Up-Regulation | 2 | 2016 | 240 | 0.220 |
Why?
|
Diabetic Angiopathies | 2 | 2014 | 47 | 0.220 |
Why?
|
Integrases | 2 | 2017 | 39 | 0.220 |
Why?
|
Morphogenesis | 3 | 2021 | 21 | 0.210 |
Why?
|
Spermatogonia | 1 | 2022 | 2 | 0.210 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 152 | 0.200 |
Why?
|
Adherens Junctions | 1 | 2022 | 8 | 0.200 |
Why?
|
Indoles | 2 | 2020 | 97 | 0.200 |
Why?
|
Inflammasomes | 1 | 2022 | 20 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2021 | 175 | 0.200 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 35 | 0.190 |
Why?
|
Mitochondria | 1 | 2024 | 332 | 0.190 |
Why?
|
Pregnancy | 3 | 2016 | 1127 | 0.190 |
Why?
|
Cytokines | 1 | 2023 | 439 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2020 | 18 | 0.180 |
Why?
|
Protein Transport | 3 | 2018 | 152 | 0.180 |
Why?
|
Paclitaxel | 1 | 2021 | 183 | 0.180 |
Why?
|
E-Selectin | 1 | 2020 | 27 | 0.170 |
Why?
|
Chemokine CCL2 | 1 | 2020 | 43 | 0.170 |
Why?
|
Down-Regulation | 3 | 2013 | 197 | 0.170 |
Why?
|
Proteomics | 1 | 2021 | 177 | 0.170 |
Why?
|
Thrombin | 1 | 2019 | 68 | 0.170 |
Why?
|
Cell Hypoxia | 1 | 2019 | 35 | 0.170 |
Why?
|
Lymphangiogenesis | 2 | 2016 | 6 | 0.170 |
Why?
|
Oxygen | 1 | 2020 | 217 | 0.170 |
Why?
|
Fibronectins | 1 | 2018 | 28 | 0.160 |
Why?
|
Bone Diseases, Developmental | 1 | 2018 | 6 | 0.160 |
Why?
|
Fluorescent Antibody Technique | 1 | 2018 | 110 | 0.160 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 18 | 0.160 |
Why?
|
Proprotein Convertases | 1 | 2018 | 11 | 0.160 |
Why?
|
Immunoblotting | 1 | 2018 | 122 | 0.150 |
Why?
|
Wound Healing | 3 | 2014 | 113 | 0.150 |
Why?
|
Serum Response Factor | 1 | 2017 | 11 | 0.150 |
Why?
|
Vascular Diseases | 1 | 2018 | 67 | 0.150 |
Why?
|
Cadherins | 1 | 2017 | 24 | 0.150 |
Why?
|
Intercellular Junctions | 1 | 2017 | 8 | 0.140 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 106 | 0.140 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 262 | 0.140 |
Why?
|
RNA Interference | 1 | 2017 | 135 | 0.140 |
Why?
|
Glycoproteins | 2 | 2016 | 118 | 0.140 |
Why?
|
Gestational Age | 1 | 2017 | 138 | 0.140 |
Why?
|
Antigens, CD | 1 | 2017 | 134 | 0.140 |
Why?
|
Transfection | 1 | 2017 | 312 | 0.140 |
Why?
|
Binding Sites | 1 | 2017 | 338 | 0.140 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 364 | 0.130 |
Why?
|
Genotype | 1 | 2017 | 441 | 0.130 |
Why?
|
Hemostasis | 1 | 2016 | 47 | 0.130 |
Why?
|
Enzyme Activation | 1 | 2016 | 262 | 0.130 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 333 | 0.130 |
Why?
|
Membrane Transport Proteins | 1 | 2016 | 64 | 0.130 |
Why?
|
Inflammation | 1 | 2019 | 601 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2015 | 34 | 0.120 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 4 | 0.120 |
Why?
|
Lymphatic System | 1 | 2014 | 11 | 0.120 |
Why?
|
Lysosomes | 3 | 2018 | 54 | 0.120 |
Why?
|
Thrombospondin 1 | 1 | 2013 | 7 | 0.110 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2013 | 7 | 0.110 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2013 | 11 | 0.110 |
Why?
|
Serpins | 1 | 2014 | 31 | 0.110 |
Why?
|
Wnt Signaling Pathway | 1 | 2014 | 54 | 0.110 |
Why?
|
Models, Cardiovascular | 1 | 2012 | 46 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 115 | 0.100 |
Why?
|
Adenosine Triphosphatases | 1 | 2012 | 47 | 0.100 |
Why?
|
Anemia | 1 | 2012 | 41 | 0.100 |
Why?
|
beta Catenin | 1 | 2012 | 62 | 0.100 |
Why?
|
Sorting Nexins | 3 | 2006 | 6 | 0.100 |
Why?
|
Frizzled Receptors | 1 | 2011 | 3 | 0.090 |
Why?
|
Hematopoiesis | 1 | 2011 | 23 | 0.090 |
Why?
|
Aging | 1 | 2018 | 943 | 0.090 |
Why?
|
Lymphopoiesis | 1 | 2011 | 22 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2011 | 275 | 0.080 |
Why?
|
Globins | 1 | 2007 | 3 | 0.080 |
Why?
|
Erythroblasts | 1 | 2007 | 3 | 0.080 |
Why?
|
Time Factors | 4 | 2014 | 1563 | 0.080 |
Why?
|
Receptor, TIE-2 | 1 | 2007 | 8 | 0.080 |
Why?
|
Blood Cells | 1 | 2007 | 10 | 0.080 |
Why?
|
Fibroblasts | 2 | 2005 | 152 | 0.070 |
Why?
|
ErbB Receptors | 2 | 2004 | 96 | 0.070 |
Why?
|
RNA, Messenger | 2 | 2005 | 645 | 0.070 |
Why?
|
Receptor, PAR-1 | 1 | 2006 | 7 | 0.070 |
Why?
|
Cell Movement | 3 | 2014 | 352 | 0.060 |
Why?
|
Phosphoproteins | 1 | 2006 | 115 | 0.060 |
Why?
|
Biological Transport | 1 | 2005 | 109 | 0.060 |
Why?
|
Hyaluronan Receptors | 1 | 2005 | 29 | 0.060 |
Why?
|
Multiprotein Complexes | 1 | 2005 | 50 | 0.060 |
Why?
|
Integrin alpha4beta1 | 1 | 2024 | 4 | 0.060 |
Why?
|
CD18 Antigens | 1 | 2024 | 14 | 0.060 |
Why?
|
Survival Rate | 1 | 2005 | 406 | 0.060 |
Why?
|
Aortic Diseases | 1 | 2024 | 16 | 0.060 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 110 | 0.060 |
Why?
|
Plaque, Atherosclerotic | 1 | 2024 | 44 | 0.060 |
Why?
|
Aorta | 1 | 2024 | 123 | 0.060 |
Why?
|
Cell Death | 1 | 2023 | 110 | 0.050 |
Why?
|
Monocytes | 1 | 2024 | 131 | 0.050 |
Why?
|
Energy Metabolism | 1 | 2024 | 178 | 0.050 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 9 | 0.050 |
Why?
|
Gonads | 1 | 2022 | 7 | 0.050 |
Why?
|
Collagen | 2 | 2018 | 147 | 0.050 |
Why?
|
Lipids | 1 | 2023 | 195 | 0.050 |
Why?
|
Mammals | 1 | 2022 | 46 | 0.050 |
Why?
|
Epothilones | 1 | 2021 | 5 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 278 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2014 | 766 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2022 | 394 | 0.040 |
Why?
|
Rats | 2 | 2018 | 1544 | 0.040 |
Why?
|
Endocytosis | 2 | 2014 | 81 | 0.040 |
Why?
|
Mutation | 2 | 2018 | 818 | 0.040 |
Why?
|
Oxidative Stress | 1 | 2023 | 623 | 0.040 |
Why?
|
Mannosephosphates | 1 | 2018 | 5 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2018 | 26 | 0.040 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 31 | 0.040 |
Why?
|
Genetic Diseases, Inborn | 1 | 2018 | 20 | 0.040 |
Why?
|
Chondrocytes | 1 | 2018 | 26 | 0.040 |
Why?
|
Lipogenesis | 1 | 2018 | 29 | 0.040 |
Why?
|
Endoplasmic Reticulum | 1 | 2018 | 77 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 131 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 115 | 0.040 |
Why?
|
Homeostasis | 1 | 2018 | 114 | 0.040 |
Why?
|
Naphthalenes | 1 | 2014 | 17 | 0.030 |
Why?
|
Lymphedema | 1 | 2014 | 13 | 0.030 |
Why?
|
Crosses, Genetic | 1 | 2014 | 36 | 0.030 |
Why?
|
Endosomes | 2 | 2006 | 44 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 1087 | 0.030 |
Why?
|
Cell Separation | 1 | 2014 | 55 | 0.030 |
Why?
|
Lymph | 1 | 2014 | 5 | 0.030 |
Why?
|
HeLa Cells | 2 | 2006 | 206 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2014 | 100 | 0.030 |
Why?
|
Plasmids | 1 | 2014 | 121 | 0.030 |
Why?
|
Hair Follicle | 1 | 2014 | 8 | 0.030 |
Why?
|
Lithium | 1 | 2014 | 8 | 0.030 |
Why?
|
Ligands | 1 | 2014 | 168 | 0.030 |
Why?
|
Lymph Nodes | 1 | 2014 | 95 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2014 | 40 | 0.030 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2014 | 31 | 0.030 |
Why?
|
RNA, Small Interfering | 2 | 2006 | 194 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2005 | 283 | 0.030 |
Why?
|
Genes, Reporter | 1 | 2014 | 88 | 0.030 |
Why?
|
Alleles | 1 | 2014 | 347 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2014 | 282 | 0.030 |
Why?
|
Microcirculation | 1 | 2014 | 111 | 0.030 |
Why?
|
Zebrafish | 1 | 2014 | 95 | 0.030 |
Why?
|
Gene Expression | 2 | 2006 | 406 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2014 | 453 | 0.030 |
Why?
|
Skin | 1 | 2014 | 140 | 0.030 |
Why?
|
Models, Biological | 1 | 2014 | 446 | 0.020 |
Why?
|
Genes, Lethal | 1 | 2011 | 6 | 0.020 |
Why?
|
Phosphorylcholine | 1 | 2011 | 11 | 0.020 |
Why?
|
Immunoglobulin Class Switching | 1 | 2011 | 9 | 0.020 |
Why?
|
Cell Lineage | 1 | 2011 | 44 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 441 | 0.020 |
Why?
|
Antibodies | 1 | 2011 | 124 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 322 | 0.020 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2006 | 6 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2006 | 98 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2005 | 11 | 0.020 |
Why?
|
Exons | 1 | 2005 | 41 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2005 | 44 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 228 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2005 | 204 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2005 | 117 | 0.010 |
Why?
|
Transcription Factor TFIIIB | 1 | 2004 | 1 | 0.010 |
Why?
|
Protein Interaction Mapping | 1 | 2004 | 34 | 0.010 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2004 | 29 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2004 | 67 | 0.010 |
Why?
|
Hyaluronic Acid | 1 | 2005 | 94 | 0.010 |
Why?
|
Point Mutation | 1 | 2004 | 60 | 0.010 |
Why?
|
Gene Silencing | 1 | 2004 | 63 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2004 | 110 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 407 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2005 | 586 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 545 | 0.010 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2004 | 129 | 0.010 |
Why?
|
Fetal Viability | 1 | 2002 | 1 | 0.010 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2002 | 12 | 0.010 |
Why?
|
Gene Targeting | 1 | 2002 | 16 | 0.010 |
Why?
|
Middle Aged | 1 | 2014 | 6803 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 2002 | 52 | 0.010 |
Why?
|
Fetal Growth Retardation | 1 | 2002 | 30 | 0.010 |
Why?
|
Protein Binding | 1 | 2004 | 631 | 0.010 |
Why?
|
Adult | 1 | 2014 | 7365 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2002 | 161 | 0.010 |
Why?
|